Detection of somatic β-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD)

Clinical Endocrinology

Volumn 69, Issue 3, 2008, Pages 367-373

  Tadjine, Mimi ^a   Lampron, Antoine ^a   Ouadi, Lydia ^a   Horvath, Anelia ^b   Stratakis, Constantine A ^b   Bourdeau, Isabelle ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; DEXAMETHASONE; PHOSPHODIESTERASE; PHOSPHODIESTERASE 11A; PROTEIN CTNNB1; PROTEIN KINASE; PROTEIN PRKAR1A;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX DISEASE; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; CUSHING SYNDROME; DNA DETERMINATION; EXON; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MISSENSE MUTATION; PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE; PRIORITY JOURNAL;

ADENOMA; ADOLESCENT; ADRENAL CORTEX DISEASES; ADRENAL CORTEX NEOPLASMS; ADULT; BETA CATENIN; CHILD; CHILD, PRESCHOOL; CYCLIC AMP-DEPENDENT PROTEIN KINASE RIALPHA SUBUNIT; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC SCREENING; HUMANS; MALE; MIDDLE AGED; MUTATION; PHOSPHORIC DIESTER HYDROLASES; PIGMENTATION DISORDERS; YOUNG ADULT;

EID: 49649127949     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03273.x     Document Type: Article

References (27)

1. Bourdeau, I. (2004) Clinical and molecular genetic studies of bilateral adrenal hyperplasias. Endocrine Research, 30, 575 583.
2. Lacroix, A. Bourdeau, I. (2005) Bilateral adrenal Cushing's syndrome: macronodular adrenal hyperplasia and primary pigmented nodular adrenocortical disease. Endocrinology Metabolism Clinics North America, 34, 441 458.
3. Bourdeau, I., Lampron, A., Costa, M.H., Tadjine, M. Lacroix, A. (2007) Adrenocorticotropic hormone-independent Cushing's syndrome. Current Opinion in Endocrinology, Diabetes and Obesity, 14, 219 225.
4. Stratakis, C.A., Kirschner, L.S. Carney, J.A. (2001) Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. Journal of Clinical Endocrinology and Metabolism, 86, 4041 4046.
5. Kirschner, L.S., Carney, J.A., Pack, S.D., Taymans, S.E., Giatzakis, C., Cho, Y.S., Cho-Chung, Y.S. Stratakis, C.A. (2000) Mutations of the gene encoding the protein kinase A type I-α regulatory subunit in patients with the Carney complex. Nature Genetics, 26, 89 92.
6. Horvath, A., Boikos, S., Giatzakis, C., Robinson-White, A., Groussin, L., Griffin, K.J., Stein, E., Levine, E., Delimpasi, G., Hsiao, H.P., Keil, M., Heyerdahl, S., Matyakhina, L., Libè, R., Fratticci, A., Kirschner, L.S., Cramer, K., Gaillard, R.C., Bertagna, X., Carney, J.A., Bertherat, J., Bossis, I. Stratakis, C.A. (2006) A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia. Nature Genetics, 38, 794 800.
7. Horvath, A., Giatzakis, C., Robinson-White, A., Boikos, S., Levine, E., Griffin, K., Stein, E., Kamvissi, V., Soni, P., Bossis, I., de Herder, W., Carney, J.A., Bertherat, J., Gregersen, P.K., Remmers. E.F. Stratakis, C.A. (2006) Adrenal hyperplasia and adenomas are associated with inhibition of phosphodiesterase 11A in carriers of PDE11A sequence variants that are frequent in the population. Cancer Research, 66, 11571 11575.
8. Stratakis, C.A. (2007) Adrenocortical tumors, primary pigmented adrenocortical disease (PPNAD)/Carney complex, and other bilateral hyperplasias: the NIH studies. Hormone and Metabolic Research, 39, 467 473.
9. Tadjine, M., Lampron, A., Ouadi, L. Bourdeau, I. (2008) Frequent mutations of β-catenin gene in sporadic secreting adrenocortical adenomas. Clinical Endocrinology, 68, 264 270.
10. Tissier, F., Cavard, C., Groussin, L., Perlemoine, K., Fumey, G., Hagnere, A.M., René-Corail, F., Jullian, E., Gicquel, C., Bertagna, X., Vacher-Lavenu, M.C., Perret, C. Bertherat, J. (2005) Mutations of β-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. Cancer Research, 65, 7622 7627.
11. Polakis, P. (2000) Wnt signaling and cancer. Genes and Development, 14, 1837 1851.
12. Kikuchi, A. (2003) Tumor formation by genetic mutations in the components of the Wnt signaling pathway. Cancer Science, 94, 225 229.
13. Salahshor, S. Woodgett, J.R. (2005) The links between axin and carcinogenesis. Journal of Clinical Pathology, 58, 225 236.
14. Gregorieff, A. Clevers, H. (2005) Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes and Development, 19, 877 890.
15. Reya, T. Clevers, H. (2005) Wnt signalling in stem cells and cancer. Nature, 434, 843 850.
16. Moon, R.T., Kohn, A.D., De Ferrari, G.V. Kaykas, A. (2004) WNT and β-catenin signalling: diseases and therapies. Nature Review of Genetics, 5, 691 701.
17. Ilyas, M., Tomlinson, I.P., Rowan, A., Pignatelli, M. Bodmer, W.F. (1997) β-catenin mutations in cell lines established from human colorectal cancers. Proceedings of the National Academy of Sciences of USA, 94, 10330 10334.
18. He, T.C., Sparks, A.B., Rago, C., Hermeking, H., Zawel, L., da Costa, L.T., Morin, P.J., Vogelstein, B. Kinzler, K.W. (1998) Identification of C-MYC as a target of the APC pathway. Science, 281, 1509 1512.
19. Tetsu, O. McCormick, F. (1999) β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature, 398, 422 426.
20. Kirschner, L.S., Sandrini, F., Monbo, J., Lin, J.P., Carney, J.A. Stratakis, C.A. (2000) Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex. Human Molecular Genetics, 9, 3037 3046.
21. Stratakis, C.A., Sarlis, N., Kirschner, L.S., Carney, J.A., Doppman, J.L., Nieman, L.K., Chrousos, G.P. Papanicolaou, D.A. (1999) Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease. Annals of Internal Medicine, 131, 585 591.
22. Bourdeau, I., Lacroix, A., Schurch, W., Caron, P., Antakly, T. Stratakis, C.A. (2003) Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in vitro and are associated with increased expression of the glucocorticoid receptor. Journal of Clinical Endocrinology and Metabolism, 88, 3931 3937.
23. Giordano, T.J., Thomas, D.G., Kuick, R., Lizyness, M., Misek, D.E., Smith, A.L., Sanders, D., Aljundi, R.T., Gauger, P.G., Thompson, N.W. Taylor J.M.G. Hanash, S.M. (2003) Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis. American Journal of Pathology, 162, 521 531.
24. Bourdeau, I., Antonini, S.R., Lacroix, A., Kirschner, L.S., Matyakhina, L., Lorang, D., Libutti, S.K. Stratakis, C.A. (2004) Gene array analysis of macronodular adrenal hyperplasia confirms clinical heterogeneity and identifies several candidate genes as molecular mediators. Oncogene, 23, 1575 1585.
25. Hagen, T. Vidal-Puig, A. (2002) Characterisation of the phosphorylation of β-catenin at the GSK-3 priming site Ser45. Biochemistry and Biophysics Research Communications, 294, 324 328.
26. Kimelman, D. Xu, W. (2006) β-catenin destruction complex: insights and questions from a structural perspective. Oncogene, 25, 7482 7491.
27. Chen, A.E., Ginty, D.D. Fan, C.M. (2005) Protein kinase A signalling via CREB controls myogenesis induced by Wnt proteins. Nature, 433, 317 322.